PR Newswire Clinical TrialsOriginal article
Published Randomized Comparative Data Demonstrate Superior Outcomes with Dayspring in Adults Aged 65 and Older and Patients with Phlebolymphedema
Data ReadoutpositiveDayspringPositive
AI Analysis
Summary
Koya Medical announced published randomized comparative data showing Dayspring demonstrated superior outcomes for lower-extremity lymphedema in adults aged 65+ and patients with phlebolymphedema, extending evidence across two clinically important populations.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
Randomized comparative data demonstrating superior outcomes in adults aged 65+ and patients with phlebolymphedema
Importance:6/10
Sentiment:
0.70
lymphedemaclinical datahead-to-head comparisongeriatric populationmedical device
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on July 23, 2026 10:00 AM